AlphaFold predicted structure
IDS · P22304

Mean pLDDT
93.1/ 100
Very high
550 residues
Confidence breakdown
- Very high(≥ 90)88%
- Confident(70–90)4%
- Low(50–70)2%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
iduronate 2-sulfatase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesFetal anomalies
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesGastrointestinal neuromuscular disorders
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Hydrocephalus
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Intellectual disability
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesLikely inborn error of metabolism
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesLysosomal storage disorder
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesMucopolysaccharideosis, Gaucher, Fabry
X-LINKED: hemizygous mutation in males, biallelic mutations in females+7 more panels — install the extension to see the full list inline on any page.
mucopolysaccharidosis type 2
hereditary disease
mucopolysaccharidosis
mucopolysaccharidosis type 2, severe form
mucopolysaccharidosis type 3A
mucopolysaccharidosis type 2, attenuated form
epidermolysis bullosa simplex with nail dystrophy
cranioectodermal dysplasia
3M syndrome
mandibuloacral dysplasia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Iduronate 2-sulfatase
Lysosomal enzyme involved in the degradation pathway of dermatan sulfate and heparan sulfate
IDS · P22304

Mean pLDDT
93.1/ 100
Very high
550 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0